Literature DB >> 21309926

Failure of complete recanalization is associated with poor outcome after cardioembolic stroke.

H S Nam1, K-Y Lee, Y D Kim, H-Y Choi, H-J Cho, M-J Cha, C M Nam, J H Heo.   

Abstract

BACKGROUND: Recanalization is strongly associated with outcomes after thrombolytic treatment. Cardiac emboli are known as better response to fibrinolytic agents because they are fibrin-rich; however, cardioembolic stroke itself is associated with poor outcomes and high mortality. Completeness of recanalization may therefore affect the outcome of cardioembolic stroke. We investigated whether degree of recanalization influences outcomes following fibrinolytic therapy in cardioembolic stroke.
METHODS: Consecutive stroke patients with relevant artery occlusions on baseline CT angiography who had received thrombolytic treatment were enrolled. Completeness of recanalization was assessed by the Thrombolysis in Myocardial Infarction (TIMI) grade, which was compared between patients with and without cardiac sources of embolism (CSE). We also investigated independent predictors of poor outcome (modified Rankin scale score 3-6) at 3 months.
RESULTS: Of the 127 patients enrolled, 65 (51%) had one or more CSE. Although the overall recanalization rates (TIMI 2 or 3) in patients with CSE (65%) and patients without CSE (68%) were similar (P=0.710), patients with CSE were less likely to show complete recanalization (TIMI 3) compared with those without CSE (19% vs. 39%, P=0.011). Multivariate analysis revealed that CSE was associated with failure of complete recanalization (OR 2.809, 95% CI 1.097-7.192) and was an independent predictor of poor outcome at 3months (OR 3.629, 95% CI 1.205-8.869).
CONCLUSIONS: In cardioembolic strokes, failure of complete recanalization following thrombolytic therapy was frequent and was associated with poor outcome after thrombolysis.
© 2011 The Author(s). European Journal of Neurology © 2011 EFNS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309926     DOI: 10.1111/j.1468-1331.2011.03360.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

Review 1.  Pharmacological revascularization of acute ischaemic stroke: focus on challenges and novel strategies.

Authors:  Didier Smadja
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

2.  Predictive Factors for Functional Outcomes After Intravenous Thrombolytic Therapy in Acute Ischemic Stroke.

Authors:  Mustafa Çetiner; Hasan Emre Aydin; Merve Güler; Sibel Canbaz Kabay; Yaşar Zorlu
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-13       Impact factor: 2.389

3.  Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.

Authors:  Osama O Zaidat; Albert J Yoo; Pooja Khatri; Thomas A Tomsick; Rüdiger von Kummer; Jeffrey L Saver; Michael P Marks; Shyam Prabhakaran; David F Kallmes; Brian-Fred M Fitzsimmons; J Mocco; Joanna M Wardlaw; Stanley L Barnwell; Tudor G Jovin; Italo Linfante; Adnan H Siddiqui; Michael J Alexander; Joshua A Hirsch; Max Wintermark; Gregory Albers; Henry H Woo; Donald V Heck; Michael Lev; Richard Aviv; Werner Hacke; Steven Warach; Joseph Broderick; Colin P Derdeyn; Anthony Furlan; Raul G Nogueira; Dileep R Yavagal; Mayank Goyal; Andrew M Demchuk; Martin Bendszus; David S Liebeskind
Journal:  Stroke       Date:  2013-08-06       Impact factor: 7.914

Review 4.  Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke.

Authors:  Precious Jolugbo; Robert A S Ariëns
Journal:  Stroke       Date:  2021-02-10       Impact factor: 7.914

5.  Efficacy of Solitaire Stent Arterial Embolectomy in Treating Acute Cardiogenic Cerebral Embolism in 17 Patients.

Authors:  Maolin Fu; Wenqin He; Weizheng Dai; Yingan Ye; Zhifang Ruan; Shuanghu Wang; Huifang Xie
Journal:  Med Sci Monit       Date:  2016-04-19

6.  Susceptibility-Weighted Imaging for Detection of Thrombus in Acute Cardioembolic Stroke.

Authors:  Min-Gyu Park; Se-Jin Oh; Seung Kug Baik; Dae Soo Jung; Kyung-Pil Park
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.